BridgeBio Pharma, Inc. (BBIO) NASDAQ
71.67
-2.77(-3.72%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
71.67
-2.77(-3.72%)
Currency In USD
| Market Cap | 15.09B |
| Enterprise Value | 17.25B |
| P/E Ratio | -19.38 |
| PEG Ratio | 0.61 |
| Price/Sales Ratio | 27.67 |
| Price/Book Ratio | -6.81 |
| Enterprise/Revenue | 31.97 |
| Enterprise/EBITDA | -25.79 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -1.45 |
| Operating Margin | -1.13 |
| Return On Assets | -0.78 |
| Return On Equity | 0.39 |
| Revenue | 502.08M |
| Revenue/Share | 2.55 |
| Gross Profit | 473.81M |
| EBITDA | -672.88M |
| Net Income | -729.31M |
| Diluted EPS | -3.79 |
| Total Cash | 587.48M |
| Total Cash/Share | 2.98 |
| Total Debt | 2.73B |
| Total Debt/Equity | -1.31 |
| Current Ratio | 2.62 |
| Book Value Per Share | -10.53 |
| 52-Week Change | 103.43 |
| 52-Week High | 84.94 |
| 52-Week Low | 31.77 |
| Moving Average 50 Days | 71.54 |
| Moving Average 200 Days | 63.51 |
| Average Volume | 2.47M |
| Shares Outstanding | 193.86M |
| % Held by Institutions | 100.29 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |